Role of Optineurin in Ocular Herpes Infection
Optineurin 在眼部疱疹感染中的作用
基本信息
- 批准号:8430175
- 负责人:
- 金额:$ 23.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-02-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAmyotrophic Lateral SclerosisAnimal ModelAntibodiesAreaAutophagocytosisBindingBiological AssayBlindnessBrainCell fusionCell membraneCell surfaceCellsCessation of lifeCo-ImmunoprecipitationsComplexCorneaDataDegenerative DisorderDiagnosticDown-RegulationDoxycyclineEpithelial CellsEtiologyExocytosisEyeEye InfectionsFutureGenesGlaucomaGlycoproteinsGolgi ApparatusGrowthHerpesvirus 1Herpetic KeratitisHumanImmunofluorescence ImmunologicInfectionInfection ControlIntegration Host FactorsInterferonsInvestigationJointsLaboratoriesLifeLinkLytic PhaseMovementMusPhosphorylationPlayProcessProductionProtein BiosynthesisProteinsRNA InterferenceRNA VirusesRegulationReportingResolutionRoleSecretory VesiclesSurfaceTANK-binding kinase 1TestingTetanus Helper PeptideTimeTissuesVaccinesVesicleViralViral InterferenceViral ProteinsVirusVirus Diseasesadapter proteinbasecell typecellular imagingcofactorcorneal epitheliuminhibition of autophagymutantmyosin VInoveloverexpressionprotein transportpublic health relevanceresponse
项目摘要
DESCRIPTION (provided by applicant): Herpes simplex virus type-1 (HSV-1) can cause irreversible damage to the human cornea and is capable of infecting virtually all major cell types in the eye. The virus is also considered a cofactor in causation of secondary glaucoma and is thought to play similar roles in certain degenerative diseases of the human brain. A lytic infection by HSV-1 is known to down regulate host protein synthesis to favor viral protein production. Very limited information is available on the host proteins that are up-regulated during the infection. This proposal is focused on understanding the function(s) of a cellular protein, optineurin (OPTN), an autophagy adapter protein, in HSV-1 infection of the eye. The gene encoding OPTN has been implicated in glaucoma and amyotrophic lateral sclerosis. Our preliminary data shows that OPTN is widely expressed in human and murine corneas. We have also found that OPTN is up-regulated in response to HSV-1 infection of human corneal epithelial (HCE) cells and transient over-expression of OPTN in HCE cells results in an increased number of plaques formed by HSV-1. This exploratory proposal will test the hypothesis that OPTN is a key to a productive infection of the human corneal cells by HSV-1. We propose to explore two independent roles for OPTN in HSV-1 infection. The first Aim will focus on the possibility that HSV-1 infection interferes with OPTN phosphorylation by TANK binding kinase-1 (TBK1), which in turn results in the inhibition of autophagy induction and interferon production, and viral replication ensues. The second Aim will examine a role for OPTN, via interaction with myosin VI, in the transport of newly made HSV-1 glycoproteins and fusion of virus-laden vesicles with the plasma membrane that facilitate the virus release from cells. Overall, our studies are expected to shed new lights, and for the first time, implicate OPTN as an important co-factor in HSV-1 infection of the cells in the cornea.
描述(由申请人提供):1 型单纯疱疹病毒 (HSV-1) 可对人类角膜造成不可逆的损伤,并且能够感染眼睛中几乎所有主要细胞类型。该病毒也被认为是导致继发性青光眼的辅助因子,并且被认为在人类大脑的某些退行性疾病中发挥类似的作用。众所周知,HSV-1 的裂解性感染会下调宿主蛋白质合成,从而有利于病毒蛋白质的产生。关于感染期间上调的宿主蛋白的信息非常有限。该提案的重点是了解细胞蛋白 optineurin (OPTN)(一种自噬衔接蛋白)在眼睛 HSV-1 感染中的功能。编码 OPTN 的基因与青光眼和肌萎缩侧索硬化症有关。我们的初步数据显示 OPTN 在人类和小鼠角膜中广泛表达。我们还发现,OPTN 在人角膜上皮 (HCE) 细胞的 HSV-1 感染反应中上调,并且 HCE 细胞中 OPTN 的瞬时过度表达导致 HSV-1 形成的斑块数量增加。该探索性提案将检验以下假设:OPTN 是 HSV-1 有效感染人类角膜细胞的关键。我们建议探索 OPTN 在 HSV-1 感染中的两个独立作用。第一个目标将关注 HSV-1 感染通过 TANK 结合激酶 1 (TBK1) 干扰 OPTN 磷酸化的可能性,从而抑制自噬诱导和干扰素产生,并随之发生病毒复制。第二个目标将通过与肌球蛋白 VI 相互作用,研究 OPTN 在新制造的 HSV-1 糖蛋白的运输以及载有病毒的囊泡与质膜的融合(促进病毒从细胞中释放)中的作用。总体而言,我们的研究有望揭示新的线索,并首次表明 OPTN 是角膜细胞 HSV-1 感染的重要辅助因子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEEPAK SHUKLA其他文献
DEEPAK SHUKLA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEEPAK SHUKLA', 18)}}的其他基金
A small molecule inhibitor of HSV genital infections
HSV 生殖器感染的小分子抑制剂
- 批准号:
10205994 - 财政年份:2018
- 资助金额:
$ 23.93万 - 项目类别:
A small molecule inhibitor of HSV genital infections
HSV 生殖器感染的小分子抑制剂
- 批准号:
9763444 - 财政年份:2018
- 资助金额:
$ 23.93万 - 项目类别:
A new molecular therapy against ocular herpes
一种针对眼部疱疹的新分子疗法
- 批准号:
10557908 - 财政年份:2015
- 资助金额:
$ 23.93万 - 项目类别:
A new molecular therapy against ocular herpes
一种针对眼部疱疹的新分子疗法
- 批准号:
10363614 - 财政年份:2015
- 资助金额:
$ 23.93万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 23.93万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 23.93万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 23.93万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 23.93万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 23.93万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 23.93万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 23.93万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 23.93万 - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 23.93万 - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 23.93万 - 项目类别:
Operating Grants